| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |